267 related articles for article (PubMed ID: 8542506)
1. The antibody to plasminogen activator inhibitor-1 suppresses pulmonary metastases of human fibrosarcoma in athymic mice.
Tsuchiya H; Katsuo S; Matsuda E; Sunayama C; Tomita K; Ueda Y; Binder BR
Gen Diagn Pathol; 1995 May; 141(1):41-8. PubMed ID: 8542506
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 accelerates lung metastasis formation of human fibrosarcoma cells.
Tsuchiya H; Sunayama C; Okada G; Matsuda E; Tomita K; Binder BR
Anticancer Res; 1997; 17(1A):313-6. PubMed ID: 9066670
[TBL] [Abstract][Full Text] [Related]
3. Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.
Soff GA; Sanderowitz J; Gately S; Verrusio E; Weiss I; Brem S; Kwaan HC
J Clin Invest; 1995 Dec; 96(6):2593-600. PubMed ID: 8675623
[TBL] [Abstract][Full Text] [Related]
4. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.
Gutierrez LS; Schulman A; Brito-Robinson T; Noria F; Ploplis VA; Castellino FJ
Cancer Res; 2000 Oct; 60(20):5839-47. PubMed ID: 11059781
[TBL] [Abstract][Full Text] [Related]
5. Role of activated protein C in facilitating basement membrane invasion by tumor cells.
Kobayashi H; Moniwa N; Gotoh J; Sugimura M; Terao T
Cancer Res; 1994 Jan; 54(1):261-7. PubMed ID: 8261450
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the metastasis of Lewis lung carcinoma by antibody against urokinase-type plasminogen activator in the experimental and spontaneous metastasis model.
Kobayashi H; Gotoh J; Shinohara H; Moniwa N; Terao T
Thromb Haemost; 1994 Apr; 71(4):474-80. PubMed ID: 8052966
[TBL] [Abstract][Full Text] [Related]
7. Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene-deficient mice.
Almholt K; Nielsen BS; Frandsen TL; Brünner N; Danø K; Johnsen M
Oncogene; 2003 Jul; 22(28):4389-97. PubMed ID: 12853975
[TBL] [Abstract][Full Text] [Related]
8. Indication of a role of plasminogen activator inhibitor type I in protecting murine fibrosarcoma cells against apoptosis.
Rømer MU; Kirkebjerg Due A; Knud Larsen J; Hofland KF; Christensen IJ; Buhl-Jensen P; Almholt K; Lerberg Nielsen O; Brünner N; Lademann U
Thromb Haemost; 2005 Oct; 94(4):859-66. PubMed ID: 16270643
[TBL] [Abstract][Full Text] [Related]
9. Loss of the metastatic phenotype by a human epidermoid carcinoma cell line, HEp-3, is accompanied by increased expression of tissue inhibitor of metalloproteinase 2.
Testa JE
Cancer Res; 1992 Oct; 52(20):5597-603. PubMed ID: 1327511
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activators in nude mice xenotransplanted with human tumorigenic cells.
Colombi M; Bellotti D; De Petro G; Barlati S
Invasion Metastasis; 1995; 15(1-2):22-33. PubMed ID: 7672929
[TBL] [Abstract][Full Text] [Related]
11. Modulation of metastatic potential by cell surface urokinase of murine melanoma cells.
Hearing VJ; Law LW; Corti A; Appella E; Blasi F
Cancer Res; 1988 Mar; 48(5):1270-8. PubMed ID: 2963689
[TBL] [Abstract][Full Text] [Related]
12. The expression of the urokinase plasminogen activator system in metastatic murine osteosarcoma: an in vivo mouse model.
Fisher JL; Mackie PS; Howard ML; Zhou H; Choong PF
Clin Cancer Res; 2001 Jun; 7(6):1654-60. PubMed ID: 11410503
[TBL] [Abstract][Full Text] [Related]
13. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).
Krüger A; Soeltl R; Lutz V; Wilhelm OG; Magdolen V; Rojo EE; Hantzopoulos PA; Graeff H; Gänsbacher B; Schmitt M
Cancer Gene Ther; 2000 Feb; 7(2):292-9. PubMed ID: 10770639
[TBL] [Abstract][Full Text] [Related]
14. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
[TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of the urokinase-type plasminogen activator and its inhibitors in squamous cell carcinoma of human larynx].
Zhao EM; Han DM; Yu ZK; Fan EZ; Li Y
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 38(1):39-42. PubMed ID: 12778766
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cells.
Chorostowska-Wynimko J; Swiercz R; Skrzypczak-Jankun E; Selman SH; Jankun J
Oncol Rep; 2004 Dec; 12(6):1155-62. PubMed ID: 15547731
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
Quemener C; Gabison EE; Naïmi B; Lescaille G; Bougatef F; Podgorniak MP; Labarchède G; Lebbé C; Calvo F; Menashi S; Mourah S
Cancer Res; 2007 Jan; 67(1):9-15. PubMed ID: 17210677
[TBL] [Abstract][Full Text] [Related]
18. Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes.
Yu HR; Schultz RM
Cancer Res; 1990 Dec; 50(23):7623-33. PubMed ID: 1701350
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse.
Ossowski L; Russo-Payne H; Wilson EL
Cancer Res; 1991 Jan; 51(1):274-81. PubMed ID: 1988089
[TBL] [Abstract][Full Text] [Related]
20. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]